Bartlett & Co Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.33M | Buy |
12,231
+338
| +3% | +$58.1K | 0.03% | 201 |
|
|
2026
Q1 | $2.02M | Sell |
11,893
-337
| -3% | -$57.6K | 0.03% | 209 |
|
|
2025
Q4 | $2.06M | Buy |
12,230
+2,713
| +29% | +$441K | 0.03% | 201 |
|
|
2025
Q3 | $1.37M | Buy |
9,517
+195
| +2% | +$26.6K | 0.02% | 238 |
|
|
2025
Q2 | $1.18M | Hold |
9,322
| – | – | 0.02% | 240 |
|
|
2025
Q1 | $1.19M | Hold |
9,322
| – | – | 0.02% | 238 |
|
|
2024
Q4 | $1.23M | Buy |
9,322
+45
| +0.5% | +$6.33K | 0.02% | 234 |
|
|
2024
Q3 | $1.35M | Sell |
9,277
-237
| -2% | -$34.3K | 0.02% | 229 |
|
|
2024
Q2 | $1.31M | Sell |
9,514
-74
| -0.8% | -$9.88K | 0.02% | 228 |
|
|
2024
Q1 | $1.32M | Sell |
9,588
-37
| -0.4% | -$5.05K | 0.02% | 241 |
|
|
2023
Q4 | $1.32M | Hold |
9,625
| – | – | 0.02% | 248 |
|
|
2023
Q3 | $1.18M | Hold |
9,625
| – | – | 0.02% | 247 |
|
|
2023
Q2 | $1.22M | Sell |
9,625
-92
| -0.9% | -$12K | 0.02% | 249 |
|
|
2023
Q1 | $1.26M | Sell |
9,717
-57
| -0.6% | -$7.46K | 0.02% | 211 |
|
|
2022
Q4 | $1.28M | Sell |
9,774
-53
| -0.5% | -$6.85K | 0.03% | 211 |
|
|
2022
Q3 | $1.15M | Hold |
9,827
| – | – | 0.02% | 208 |
|
|
2022
Q2 | $1.16M | Hold |
9,827
| – | – | 0.02% | 204 |
|
|
2022
Q1 | $1.28M | Sell |
9,827
-120
| -1% | -$15.6K | 0.02% | 209 |
|
|
2021
Q4 | $1.52M | Buy |
9,947
+120
| +1% | +$18.6K | 0.03% | 200 |
|
|
2021
Q3 | $1.59M | Sell |
9,827
-600
| -6% | -$101K | 0.03% | 183 |
|
|
2021
Q2 | $1.71M | Buy |
10,427
+238
| +2% | +$36.7K | 0.03% | 182 |
|
|
2021
Q1 | $1.53M | Sell |
10,189
-200
| -2% | -$31.8K | 0.03% | 184 |
|
|
2020
Q4 | $1.57M | Hold |
10,389
| – | – | 0.03% | 180 |
|
|
2020
Q3 | $1.41M | Buy |
10,389
+120
| +1% | +$16.3K | 0.03% | 179 |
|
|
2020
Q2 | $1.4M | Sell |
10,269
-20
| -0.2% | -$2.55K | 0.04% | 173 |
|
|
2020
Q1 | $1.11M | Hold |
10,289
| – | – | 0.03% | 185 |
|
|
2019
Q4 | $1.24M | Hold |
10,289
| – | – | 0.03% | 195 |
|
|
2019
Q3 | $1.02M | Sell |
10,289
-765
| -7% | -$80.1K | 0.03% | 204 |
|
|
2019
Q2 | $1.21M | Buy |
11,054
+438
| +4% | +$46.6K | 0.05% | 155 |
|
|
2019
Q1 | $1.19M | Sell |
10,616
-120
| -1% | -$13.2K | 0.05% | 158 |
|
|
2018
Q4 | $1.04M | Hold |
10,736
| – | – | 0.04% | 160 |
|
|
2018
Q3 | $1.31M | Buy |
10,736
+462
| +4% | +$54.4K | 0.05% | 151 |
|
|
2018
Q2 | $1.13M | Hold |
10,274
| – | – | 0.05% | 153 |
|
|
2018
Q1 | $1.1M | Buy |
+10,274
| New | +$1.14M | 0.05% | 153 |
|
Other funds holding IBB
CB
Bartlett & Co Wealth Management's IBB Position: Q2 2026 in Review
Bartlett & Co Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 2.8% in Q2 2026, buying an estimated $58.1K and bringing the position to 12,231 shares worth $2.33M. The position accounts for 0.03% of the portfolio, ranked #201.
Bartlett & Co Wealth Management first reported a position in IBB in Q1 2018 and has held it in 34 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Bartlett & Co Wealth Management held 12,231 shares of iShares Biotechnology ETF worth $2.33M as of Q2 2026.
- Bartlett & Co Wealth Management bought 338 iShares Biotechnology ETF shares in Q2 2026, an estimated $58.1K.
- iShares Biotechnology ETF made up 0.03% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #201 holding.
- Bartlett & Co Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2018 and has held it in 34 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.